Advertisement
HomeCollectionsOtc
IN THE NEWS

Otc

FEATURED ARTICLES
FEATURES
By SUSAN BONDY and SUSAN BONDY,Creators Syndicate | July 16, 1995
Q: Is there a difference between buying a stock that is listed on an exchange and buying an over-the-counter stock?A: Here are the three major differences:* Stock prices are arrived at through different processes.* The major exchanges have more stringent requirements for listing a stock.* The prices may be quoted differently in the newspaper and by the broker.A stock exchange centralizes trading in one location -- the floor of the exchange. There, buyers and sellers come together and, following auction principles, agree on a price for the trade.
ARTICLES BY DATE
NEWS
September 24, 2014
A recent exchange within your opinion pages debated the benefit of over-the-counter access to oral contraceptives, with a letter to the editor ( "Sun wrong on OTC birth control," Sept. 16) citing the American Congress of Obstetricians and Gynecologists as being supportive of recent proposals from Congressional candidates across the country. But there's a disclaimer to our support: while ACOG does believe that many oral contraceptives are safe and effective for over-the-counter use, and we would welcome this new level of access for some women, we strongly believe that this is not enough.
Advertisement
FEATURES
By Susan Bondy and Susan Bondy,Creators Syndicate | June 23, 1996
In February, my broker recommended that I invest in a small company that makes a line of men's toiletries. On Feb. 21, I bought 1,000 shares for approximately $15,000. The stock, which traded in the over-the-counter market, was not listed in my newspaper.On April 18, my financial consultant called to tell me that my stock, which now amounted to 2,000 shares due to a stock split, was worth only about $4.50 per share and falling. I told him to sell. It was sold for $4.375 (really, this is $4 3/8 since stocks trade in eighths)
BUSINESS
By Hanah Cho, The Baltimore Sun | August 31, 2011
First Mariner Bancorp, locked in a fight for survival, suffered another setback Wednesday when its stock was delisted from the Nasdaq stock market. Starting Thursday, First Mariner shares will be traded on the over-the-counter bulletin board. The latest development comes as the company is trying to raise desperately needed capital to close a deal that would keep regulators at bay and the bank in business. The deal requires the Baltimore company to raise nearly $124 million by Thursday or risk losing a cash infusion from a New York investment firm.
NEWS
By Joe Graedon and Teresa Graedon and Joe Graedon and Teresa Graedon,KING FEATURES SYNDICATE | November 23, 2003
Is there any difference between over-the-counter Claritin and the Claritin my doctor used to prescribe? When my doctor switched me from prescription Zantac to Zantac 75, he told me I would have to take two pills instead of one. Is the same situation true for Claritin? In the past, the Food and Drug Administration frequently approved lower doses when a prescription drug went over the counter. More recently, however, doses haven't been altered. Claritin and Prilosec OTC are identical in dose to their earlier prescription counterparts.
BUSINESS
By Tricia Bishop and Tricia Bishop,SUN REPORTER | December 21, 2006
Neuralstem Inc., a Rockville company hoping to develop fetal stem cell research into treatments for central nervous system diseases, expects to begin trading shares on the over-the-counter bulletin board today. It will be the second Maryland stem-cell company to go public this year. In August, Baltimore's Osiris Therapeutics Inc., which uses stem cells donated from adult volunteers and has one product on the market, began trading on Nasdaq. The stock has more than doubled since the initial offering and closed at $26 yesterday, up 96 cents from the day before.
BUSINESS
By Opinions on stocks offered by investment experts. Compiled by Steve Halpern for Knight Ridder | January 8, 1992
Spec's MusicOur favorite stock pick for 1992 is Spec's Music (SPEK, OTC, around $5), a Florida-based 59-store retailer of pre-recorded music and video products," says The Clean Yield of Greensboro Bend, Vt."Spec's was founded in 1948 by Martin Spector. The firm has managed to hold its own during the recession and the slump in the music business. Our estimate is that earnings could reach $0.50 a share during the next 12 months."At current prices, we feel the stock is selling for a song."Sound Advice"My 1992 stock of the year is Sound Advice (SUND, OTC, around $7)
BUSINESS
By Opinions on stocks offered by investment experts. Compiled by Steve Halpern for Knight-Ridder | November 6, 1991
Interneuron"Interneuron Pharmaceuticals (IPIC, OTC, around $9) is a promising young company, which began operations in 1990," says R.H.M. Survey of Warrants and Options, Glen Cove, N.Y."Wall Street is only beginning to become aware of the firm's new products. . ."And we expect many exciting things over the next year or so."We believe that the true merits of the company's products will soon become even more evident and recommend purchase at current levels."IsisIsis Pharmaceuticals (ISIP, OTC, around $21)
NEWS
September 24, 2014
A recent exchange within your opinion pages debated the benefit of over-the-counter access to oral contraceptives, with a letter to the editor ( "Sun wrong on OTC birth control," Sept. 16) citing the American Congress of Obstetricians and Gynecologists as being supportive of recent proposals from Congressional candidates across the country. But there's a disclaimer to our support: while ACOG does believe that many oral contraceptives are safe and effective for over-the-counter use, and we would welcome this new level of access for some women, we strongly believe that this is not enough.
BUSINESS
By Opinions on stocks offered by investment experts. Compiled by Steve Halpern for Knight-Ridder | May 20, 1992
Catherines StoresIndividual Investor Special Situations, New York, likes Catherines Stores (OTC, CATH, $12.875)."Catherines operates 229 stores in 35 states, offering apparel and accessories for large-sized women, size 16 or bigger. The $10 billion market for large-sized women's apparel is growing much more quickly than the industry at large. . . . CATH should report dramatic profit gains in fiscal 1992, with earnings rising from a $0.02 per share loss to a $0.70 per share gain. Next year's earnings should range between $0.85 and $0.90 per share.
NEWS
By Kelly Brewington and Kelly Brewington,Sun reporter | August 23, 2008
Federal regulators are planning to launch a broad new review of whether over-the-counter cold medicines are safe and effective for children under 12. The Food and Drug Administration said yesterday that it will hold public hearings on the medications in October, the first step in what will likely be a long study that could lead to stricter age guidelines, changes in formulas and recommended dosages, and the removal of some products from the market, said...
BUSINESS
By Gregory Karp and Gregory Karp,The Morning Call in Allentown, Pa | May 4, 2008
People who regularly take prescription drugs know generics are a lot cheaper and generally as effective. But what many people might not know is that generic over-the-counter medications are a good deal, too. Store brands from chain drugstores, large discounters and warehouse clubs have the same active ingredients as name brands and must gain approval by the Food and Drug Administration, just like the brands that are household names. So for medications, pain relievers, cough and cold remedies, vitamins and even first-aid supplies, consider buying store brands to save money.
NEWS
By Jonathan D. Rockoff and Jonathan D. Rockoff,Sun reporter | January 18, 2008
WASHINGTON -- The government issued its strongest warning yesterday about the dangers of cough and cold medicines for infants, urging parents to stop giving the over-the-counter remedies to children 2 and younger. The Food and Drug Administration released the warning out of fear that many parents have continued treating sick infants with popular pediatric cold products despite a flurry of recent reports on dangerous or fatal side effects. Recent surveys showed that a majority of parents still think it's OK to give the medicines to young children without consulting a doctor.
NEWS
By Jeremy Manier and Judith Graham and Jeremy Manier and Judith Graham,CHICAGO TRIBUNE | February 8, 2007
In a move that will expand dieters' access to a drug that has shown modest benefits and potentially embarrassing side effects, the U.S. Food and Drug Administration gave the OK yesterday for over-the-counter sales of orlistat, the first federally approved diet pill available without a prescription. Previously released in a stronger prescription form called Xenical, the nonprescription drug will be marketed by drugmaker GlaxoSmithKline PLC, which plans to call it Alli. Consumers hoping for a miracle weight-loss product are likely to be disappointed.
BUSINESS
By Tricia Bishop and Tricia Bishop,SUN REPORTER | December 21, 2006
Neuralstem Inc., a Rockville company hoping to develop fetal stem cell research into treatments for central nervous system diseases, expects to begin trading shares on the over-the-counter bulletin board today. It will be the second Maryland stem-cell company to go public this year. In August, Baltimore's Osiris Therapeutics Inc., which uses stem cells donated from adult volunteers and has one product on the market, began trading on Nasdaq. The stock has more than doubled since the initial offering and closed at $26 yesterday, up 96 cents from the day before.
NEWS
By DENNIS O'BRIEN and DENNIS O'BRIEN,SUN REPORTER | August 4, 2006
Bad news for allergy and cold sufferers -- researchers in Florida say the over-the-counter nasal decongestant that's replacing Sudafed on many drugstore shelves is ineffective. The compound phenylephrine, marketed by Pfizer Inc. as Sudafed PE, isn't sufficiently absorbed into the bloodstream to make it an effective oral medication, according to Leslie Hendeles and Randy C. Hatton, pharmacists at the University of Florida. The researchers raised the issue in a pharmaceutical journal last month because they are concerned that people will buy a medication that doesn't work -- not realizing that a better drug is available a few feet away -- if they ask for it. A Pfizer spokesman said the new drug is effective and that consumers can still ask for the original Sudafed if they want it. The problem arose this year after the Food and Drug Administration acted on complaints that criminals were buying up bulk quantities of Sudafed tablets and generic look-alikes for their key ingredient, a compound known as pseudephedrine.
BUSINESS
By Andrew Leckey and Andrew Leckey,Tribune Media Services | April 29, 1992
To get to this sleepy town of Moraga in Contra Costa County, Calif., one must drive a circuitous route through a long tunnel and a maze of narrow and wide freeways.The trip, however, features no more twists than the chosen investment path of Moraga resident James Collins, whose OTC Insight model portfolio rose 149 percent in value last year. The newsletter editor, Mr. Collins, tracks the unpredictable over-the-counter stock market, and its lackluster performance this year has resulted in a meager 2 percent portfolio gain.
BUSINESS
July 10, 1996
T. Rowe Price Associates Inc. yesterday introduced a new equity mutual fund that invests in stocks of midsized companies that are out of favor with the market.The fund is called the T. Rowe Price Mid-Cap Value Fund. It invests primarily in companies with market capitalizations ranging from $300 million to $5 billion.Mid-Cap Value is managed by Greg McCrickard, 38, who also manages T. Rowe Price's OTC Fund, which invests in small companies. The OTC Fund returned 13.85 percent in the first six months of the year and 32.9 percent for the 12 months ended June 30.McCrickard said the Mid-Cap Value Fund offers investors the "financial stability of larger companies and the higher growth potential of smaller firms."
NEWS
By JUDY FOREMAN | March 3, 2006
Do over-the-counter painkillers raise blood pressure? Some do, at least in women. In a study published last year in Hypertension, a journal of the American Heart Association, researchers from the Nurses' Health Study looked at the records of more than 5,000 female nurses ages 34 to 77. They found that those who took 500 milligrams or more a day of acetaminophen - such as Tylenol - were twice as likely to develop high blood pressure as those who didn't....
NEWS
By Jonathan D. Rockoff and Jonathan D. Rockoff,SUN NATIONAL STAFF | September 1, 2005
WASHINGTON - Accusing federal drug regulators of ignoring sound science, a top official at the Food and Drug Administration resigned yesterday to protest the agency's failure to allow sales of the "morning-after" pill without a prescription. Susan F. Wood said she left her post promoting women's health at the FDA because of the agency's decision last week indefinitely delaying approval of over-the-counter sales of the Plan B pill until it could hear more public comment and study further.
Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.